Royalty Pharma plc - Fitch Research

Royalty Pharma plc

Royalty Pharma plc - Fitch Research
Royalty Pharma plc
Published Apr 30, 2025
14 pages (6782 words) — Published Apr 30, 2025
Price US$ 300.00  |  Buy this Report Now

About This Report

  
Brief Excerpt:

...The 'BBB-' Issuer Default Rating (IDR) and Stable Outlook reflect Royalty Pharma plc's (Royalty Pharma) solid portfolio of high-quality royalty streams and cash flows. These strengths are partially offset by the sales risk associated with the biopharmaceutical products from which it receives royalties, uncertainties related to the acquisition of interests in development-stage biopharmaceutical products and revenue concentration in a few medicines....

  
Report Type:

Rating Report

Company(ies)
Royalty Pharma plc
Issuer
Royalty Pharma plc
Format:
PDF Adobe Acrobat
Buy Now

Fitch Research—Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

About the Author


Cite this Report

  
MLA:
Fitch Research. "Royalty Pharma plc" Apr 30, 2025. Alacra Store. May 01, 2025. <http://www.alacrastore.com/fitch-credit-research/Royalty-Pharma-plc-RPT_10306524>
  
APA:
Fitch Research. (2025). Royalty Pharma plc Apr 30, 2025. New York, NY: Alacra Store. Retrieved May 01, 2025 from <http://www.alacrastore.com/fitch-credit-research/Royalty-Pharma-plc-RPT_10306524>
  
US$ 300.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.